PMID- 19566553 OWN - NLM STAT- MEDLINE DCOM- 20091005 LR - 20220316 IS - 1479-828X (Electronic) IS - 0004-8666 (Linking) VI - 49 IP - 3 DP - 2009 Jun TI - Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. PG - 247-53 LID - 10.1111/j.1479-828X.2009.00999.x [doi] AB - AIM: Cytokine polymorphisms may alter the fetal inflammatory response, increasing susceptibility to cerebral palsy (CP). This study investigates associations between selected inflammatory mediator and cytokine gene polymorphisms (Toll-like receptor-4 (TLR-4) Asp299Gly, interleukin-6 G-174C and interleukin-4 C-589T) and CP from 443 CP infants and 883 control infants. Results were correlated with viral nucleic acids in the same samples. RESULTS: At all gestational ages (GA), TLR-4 was associated with a decreased risk of developing CP (homozygous/heterozygous odds ratio (OR) 0.70, 95% confidence interval (CI) 0.50-0.98) and interleukin (IL)-6 was associated with an increased risk of developing hemiplegia (OR 1.38, 95% CI 1.05-1.83). For infants born 32-36 weeks GA, there was a tenfold increase in the risk of quadriplegic CP with homozygous/heterozygous IL-6 (OR 10.42, 95% CI 1.34-80.82). Viral exposure in combination with IL-4 in preterm infants was associated with a fourfold increased risk of quadriplegia (homozygous/heterozygous OR 4.25, 95% CI 1.21-14.95). In very preterm infants, the absence of detectable viral exposure in combination with IL-4 decreased the risk of developing CP (homozygous/heterozygous OR 0.31, 95% CI 0.13-0.76). CONCLUSION: Polymorphisms in TLR-4 may be associated with a decreased risk of CP. Polymorphisms in IL-6 or IL-4 may act as susceptibility genes, in the presence of viral exposure, for the development of hemiplegic and quadriplegic CP. These associations require confirmation but they suggest a hypothesis for CP causation due to double jeopardy from neurotropic viral exposure and genetic susceptibility to infection. FAU - Djukic, Michael AU - Djukic M AD - Discipline of Obstetrics and Gynaecology, The University of Adelaide, South Australia, Australia. FAU - Gibson, Catherine S AU - Gibson CS FAU - Maclennan, Alastair H AU - Maclennan AH FAU - Goldwater, Paul N AU - Goldwater PN FAU - Haan, Eric A AU - Haan EA FAU - McMichael, Gai AU - McMichael G FAU - Priest, Kevin AU - Priest K FAU - Dekker, Gustaaf A AU - Dekker GA FAU - Hague, William M AU - Hague WM FAU - Chan, Annabelle AU - Chan A FAU - Rudzki, Zbigniew AU - Rudzki Z FAU - VAN Essen, Phillipa AU - VAN Essen P FAU - Khong, T Yee AU - Khong TY FAU - Morton, Mark R AU - Morton MR FAU - Ranieri, Enzo AU - Ranieri E FAU - Scott, Heather AU - Scott H FAU - Tapp, Heather AU - Tapp H FAU - Casey, Graeme AU - Casey G LA - eng GR - Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Australia TA - Aust N Z J Obstet Gynaecol JT - The Australian & New Zealand journal of obstetrics & gynaecology JID - 0001027 RN - 0 (IL4 protein, human) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 0 (Toll-Like Receptor 4) RN - 207137-56-2 (Interleukin-4) SB - IM MH - Case-Control Studies MH - Cerebral Palsy/*genetics/*virology MH - Female MH - Genetic Predisposition to Disease/*genetics MH - Gestational Age MH - Humans MH - Infant, Newborn MH - Interleukin-4/genetics MH - Interleukin-6/genetics MH - Odds Ratio MH - Polymorphism, Single Nucleotide/*genetics MH - Pregnancy MH - Pregnancy Complications, Infectious/*virology MH - Registries MH - Toll-Like Receptor 4/genetics MH - Virus Diseases/*complications EDAT- 2009/07/02 09:00 MHDA- 2009/10/06 06:00 CRDT- 2009/07/02 09:00 PHST- 2009/07/02 09:00 [entrez] PHST- 2009/07/02 09:00 [pubmed] PHST- 2009/10/06 06:00 [medline] AID - AJO999 [pii] AID - 10.1111/j.1479-828X.2009.00999.x [doi] PST - ppublish SO - Aust N Z J Obstet Gynaecol. 2009 Jun;49(3):247-53. doi: 10.1111/j.1479-828X.2009.00999.x.